These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6130913)

  • 21. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
    Chen L; Waxman DJ
    Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
    Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
    Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vivo studies on the transformation of cyclophosphamide to mutagenic metabolites].
    Della Morte R; Belisario MA; Farina C; Martire G; Staiano N; De Lorenzo F
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1061-7. PubMed ID: 7138675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxygen-insensitive enzymatic reduction of oximes to imines.
    Heberling S; Girreser U; Wolf S; Clement B
    Biochem Pharmacol; 2006 Jan; 71(3):354-65. PubMed ID: 16324684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
    Chang TK; Weber GF; Crespi CL; Waxman DJ
    Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic screening using on-line ultrafiltration mass spectrometry.
    van Breemen RB; Nikolic D; Bolton JL
    Drug Metab Dispos; 1998 Feb; 26(2):85-90. PubMed ID: 9456292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biotransformation of lithocholic acid by rat hepatic microsomes: metabolite analysis by liquid chromatography/mass spectrometry.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2008 Feb; 36(2):442-51. PubMed ID: 18039809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of phencyclidine. The role of iminium ion formation in covalent binding to rabbit microsomal protein.
    Ward DP; Trevor AJ; Kalir A; Adams JD; Baillie TA; Castagnoli N
    Drug Metab Dispos; 1982; 10(6):690-5. PubMed ID: 6130925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thioether adducts of a new imine reactive intermediate of the pneumotoxin 3-methylindole.
    Skordos KW; Laycock JD; Yost GS
    Chem Res Toxicol; 1998 Nov; 11(11):1326-31. PubMed ID: 9815193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro biotransformation and identification of human cytochrome P450 isozyme-dependent metabolism of tazofelone.
    Surapaneni SS; Clay MP; Spangle LA; Paschal JW; Lindstrom TD
    Drug Metab Dispos; 1997 Dec; 25(12):1383-8. PubMed ID: 9394028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of cyclophosphamide biotransformation in vivo.
    Domeyer BE; Sladek NE
    Cancer Res; 1980 Jan; 40(1):174-80. PubMed ID: 7349895
    [No Abstract]   [Full Text] [Related]  

  • 38. The comparative pharmacology of cyclophosphamide and ifosfamide.
    Colvin M
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):2-7. PubMed ID: 6761865
    [No Abstract]   [Full Text] [Related]  

  • 39. Flavin-containing monooxygenase 1-catalysed N,N-dimethylamphetamine N-oxidation.
    Lee SK; Kang MJ; Jin C; In MK; Kim DH; Yoo HH
    Xenobiotica; 2009 Sep; 39(9):680-6. PubMed ID: 19552509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoxidation of C18 unsaturated fatty acids by cytochromes P4502C2 and P4502CAA.
    Laethem RM; Balazy M; Koop DR
    Drug Metab Dispos; 1996 Jun; 24(6):664-8. PubMed ID: 8781783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.